ELVN icon

Enliven Therapeutics
ELVN

Overview Fund Activity

36 hedge funds and large institutions have $74.5M invested in Enliven Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 11 closing their positions.

Holders
36
Holders Change
+5
Holders Change %
+16.13%
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
17
Increased
9
Reduced
8
Closed
11
Calls
$1.33M
Puts
$77K
Net Calls
+$1.25M
Net Calls Change
+$3.04M

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$13.3M
2
BCM
2
BML Capital Management
Indiana
$12.3M
3
CC
3
Commodore Capital
New York
$10.2M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$3.77M
5
Citadel Advisors
5
Citadel Advisors
Florida
$3.18M

Top Sellers

1
RSCM
1
Rock Springs Capital Management
Maryland
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$874K
3
CM
3
Caption Management
Oklahoma
$0
4
Parallax Volatility Advisers
4
Parallax Volatility Advisers
California
$0
5
Group One Trading
5
Group One Trading
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
51
Concourse Financial Group Securities
Alabama
– – – –
1 2
3